Crossmark

10-day triple therapy with esomeprazole 40mg/12h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection

Crossref DOI link: https://doi.org/10.1016/j.gastre.2016.10.007

Published Print: 2016-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Campillo, Ana

Amorena, Edurne

Ostiz, Miriam

Kutz, Marcos

LaIglesia, Matilde
License Information

Text and Data Mining valid from 2016-11-01
More Information

This article is maintained by: Elsevier

Article Title: 10-day triple therapy with esomeprazole 40mg/12h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2016.10.007

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2016.03.002

Content Type: article

Copyright: © 2016 Elsevier España, S.L.U., AEEH and AEG. All rights reserved.

Document is current

Any future updates will be listed below